The genetic association between Cathepsin D and Alzheimer's disease

Neuroscience Letters

Volumn 289, Issue 1, 2000, Pages 61-65

  Crawford, F C ^a   Freeman, M J ^a   Schinka, J ^a   Abdullah, L I ^a   Richards, D ^a   Sevush, S ^b   Duara, R ^c   Mullan, M J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Mount Sinai Memory Disorder Clinic   (United States)

Author keywords

Amyloid precursor protein; Alzheimer's disease; Cathepsin D

Indexed keywords

CATHEPSIN D;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CATHEPSIN D; DATABASES, FACTUAL; FEMALE; FLORIDA; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034726017     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01260-X     Document Type: Article

References (24)

1. Adroer R., Santacruz P., Blesa R., Lopez-Pousa S., Ascaso C., Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci. Lett. 189:1995;182-186.
2. Bi X., Haque T.S., Zhou J., Skillman A.G., Lin B., Lee C.E., Kuntz I.D., Ellman J.A., Lynch G. Novel cathepsin D inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus. J. Neurochem. 74:2000;1469-1477.
3. Brown A.M., Tummolo D.M., Spruyt M.A., Jacobsen J.S., Sonnenberg-Reines J. Evaluation of cathepsins D and G and EC 3.4.24.15 as candidate beta-secretase proteases using peptide and amyloid precursor protein substrates. J. Neurochem. 66:1996;2436-2445.
4. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., Lippa C., Nixon R.A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 14:1995;671-680.
5. Chevallier N., Vizzavona J., Marambaud P., Baur C.P., Spillantini M., Fuicrand P., Martinez J., Goedert M., Vincent J.P., Checler F. Cathepsin D displays in vitro betasecretase-like specificity. Brain Res. 750:1997;11-19.
6. Evin G., Cappai R., Li Q.X., Culvenor J.G., Small D.H., Beyreuther K., Masters C.L. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of Cathepsin D. Biochemistry. 34:1995;14185-14192.
7. Gruninger-Leitch F., Berndt P., Langen H., Nelboeck P., Dobeli H. Identification of beta-secretase-like activity using a mass spectrometry-based assay system. Nat. Biotechnol. 18:2000;66-70.
8. Hamazaki H. A beta-amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin D. FEBS Lett. 397:1996;313-315.
9. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as betasecretase. Mol. Cell Neurosci. 14:1999;419-427.
10. Ibarreta D., Gomez-Isla T., Portera-Sanchez A., Parrilla R., Ayuso M.S. Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. J. Neurol. Sci. 134:1995;146-149.
11. Komano H., Seeger M., Gandy S., Wang G.T., Krafft G.A., Fuller R.S. Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretasetype cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J. Biol. Chem. 273:1998;31648-31651.
12. Mackay E.A., Ehrhard A., Moniatte M., Guenet C., Tardif C., Tarnus C., Sorokine O., Heintzelmann B., Nay C., Remy J.M., Higaki J., Van Dorsselaer A., Wagner J., Danzin C., Mamont P. A possible role for cathepsins D, E, and B in the processing of betaamyloid precursor protein in Alzheimer's disease. Eur. J. Biochem. 244:1997;414-425.
13. Mcllroy S.P., Dynan K.B., McGleenon B.M., Lawson J.T., Passmore A.P. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neurosci. Lett. 273:1999;140-141.
14. Mullan M., Scibelli P., Duara R., Fallin D., Gold M., Schinka J., Hoyne J., Osborne A., Sevush S., Crawford F. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann. N.Y. Acad. Sci. 802:1996;16-26.
15. Papassotiropoulos A., Bagli M., Feder O., Jessen F., Maier W., Rao M.L., Ludwig M., Schwab S.G., Heun R. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci. Lett. 262:1999;171-174.
16. Papassotiropoulos A., Bagli M., Kurz A., Kornhuber J., Forstl H., Maier W., Pauls J., Lautenschlager N., Heun R. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann. Neurol. 47:2000;399-403.
17. Sadik G., Kaji H., Takeda K., Yamagata F., Kameoka Y., Hashimoto K., Miyanaga K., Shinoda T. In vitro processing of amyloid precursor protein by cathepsin D. Int. J. Biochem. Cell Biol. 31:1999;1327-1337.
18. Saftig P., Peters C., von Figura K., Craessaerts K., Van Leuven F., De Strooper B. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J. Biol. Chem. 271:1996;27241-27244.
19. Sinha S., Anderson J.R., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 402:1999;537-540.
20. Touitou I., Capony F., Brouillet J.P., Rochefort H. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction-single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur. J. Cancer, 30A. 1994;390-394.
21. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
22. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
23. Wolfe M.S., Xia W., Moore C.L., Leatherwood D.D., Ostaszewski B., Rahmati T., Donkor T.O., Selkoe D.J. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry. 38:1999;4720-4727.
24. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 402:(6761):1999;533-537.